CClinicalTrials.gg
CompletedNCT01258985TCPTUpdated Aug 4, 2016Results posted

Tai Chi and Physical Therapy for Knee Osteoarthritis

An interventional study of Tai Chi and Physical Therapy in Knee Osteoarthritis, sponsored by Tufts Medical Center. Completed at 1 site in United States. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2016-08-04.

Sponsored by Tufts Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
204
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

We will conduct a large randomized controlled trial comparing the effectiveness and cost-effectiveness of Tai Chi mind-body exercise and standard-of-care Physical Therapy for Knee Osteoarthritis.

Read the detailed description

Osteoarthritis (OA) causes pain and long-term disability, and the public health impact will increase as the population ages. In addition to inconsistent effectiveness, current treatments such as nonsteroidal anti-inflammatory drugs, knee replacement, and physical therapy may be expensive, result in serious adverse effects, reduce physical function, and fail to improve mental well-being. Finding effective treatments to maintain function and quality of life in OA patients is one of the national priorities identified this year by the Institute of Medicine.

We propose to conduct the first comparative effectiveness and cost-effectiveness trial of Tai Chi vs. physical therapy (PT) in a large symptomatic Knee OA population. A single-blind, randomized, controlled trial of Tai Chi vs. Physical Therapy will be conducted in 180 patients who meet the American College of Rheumatology criteria for Knee OA. Patients will be randomized to 12 weeks of treatment with Tai Chi (2x/week) or Standard Physical Therapy (2x/week for 6 weeks, followed by 6 weeks of rigorous supervised home exercise) with 24 and 52 week follow-ups.

02

Conditions studied

  • Knee Osteoarthritis

Keywords

  • Knee
  • Knee osteoarthritis
  • osteoarthritis
  • Knee pain
  • Tai Chi
  • Physical Therapy
  • mind-body exercise
03

In context

Osteoarthritis

4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.

This study's enrollment of 204 is above the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

Tufts Medical Center is the lead sponsor of 194 studies on the registry; 28 are open to participants now.

Of its 30 completed or terminated interventional studies of FDA-regulated products, 16 (53%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 40 years and older
  • American College of Rheumatology criteria for symptomatic Knee OA: Pain on more than half the days of the past month during at least one of the following activities: walking, going up or down stairs, standing upright, or lying in bed at night;101 radiographic evidence of grade I-III tibiofemoral or patellofemoral OA: defined as the presence of osteophytes in the tibiofemoral compartment and /or the patellofemoral compartment, as assessed on standing anterior/posterior and lateral views101
  • WOMAC pain subscale score >= 40 (visual analog version) on at least 1 of 5 questions (range 0 to 100 each)
  • Clinical examination confirming knee pain or discomfort or instability referable to the knee joint
  • Physically able to participate in both the Tai Chi and Standard PT programs
  • Willing to undergo testing and intervention procedures and 1.willing to abstain from Tai Chi until completion of the program, if randomized to Standard PT regimen. 2. willing to abstain from Standard PT regimen until completion of the program, if randomized to Tai Chi

Exclusion criteria

Exclusion Criteria:

  • Prior experience with physical therapy, Tai Chi or other similar types of Complementary and Alternative Medicine in the past 1 year such as Qi gong and yoga since these share some of the principles of Tai Chi.
  • Serious medical conditions limiting the ability and safety to participate in either the Tai Chi or Standard PT regimen programs as determined by primary care physicians; these include dementia, neurological disease, symptomatic heart or vascular disease (angina, peripheral vascular disease, congestive heart failure), severe hypertension, recent stroke, severe insulin-dependent diabetes mellitus, psychiatric disease, renal disease, liver disease, active cancer and anemia
  • Any intra-articular steroid injections in the previous 3 months or reconstructive surgery on the affected knee
  • Any intra-articular Synvisc or Hyalgan injections in the previous 6 months
  • Inability to pass the Mini-Mental Status examination (with a score below 24)102
  • Inability to walk without a cane or other assistive device 100% of the time during the baseline assessments
  • Enrollment in any other clinical trial within the last 30 days
  • Plan to permanently relocate from the region during the trial period
  • Positive pregnancy test or planning pregnancy within the study period
  • Not English-Speaking
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
204 participants (actual)

Study arms

  • Active comparator
    Tai Chi

    12 weeks of Tai Chi classes

    Behavioral: Tai Chi

  • Active comparator
    Physical Therapy

    6 weeks of individualized Physical Therapy followed by 6 weeks of Supervised Home Exercise

    Behavioral: Physical Therapy

Interventions

  • BehavioralTai Chi

    12 weeks of Tai Chi

  • BehavioralPhysical Therapy

    6 weeks of individualized Physical Therapy followed by 6 weeks of supervised Home Exercise

06

What researchers measure

Primary outcomes

  1. Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC)Pain Subscale From Baseline to 12 Weeks

    The WOMAC (version: Visual Analog Scale 3.1) is a validated, self-administered, visual analogue scale specifically designed to evaluate knee and hip osteoarthritis. It has three subscales that are analyzed separately: pain (score range, 0-500), stiffness (0-200), and function (0-1700), with higher scores indicating more severe disease.

    Time frame: From Week 0 to Week 12

Secondary outcomes

  1. Change in Medical Outcomes Short Form-36 PCS

    The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) Physical Component Score (PCS) is the summary score for the physical quality-of-life components (range, 0 to 100, with higher scores indicating better health status)

    Time frame: From Week 0, to Week 12, or to week 24, or to week 52

  2. Change in 6 Minute Walk

    The 6 minute Walk Test is a measure of functional exercise capacity. Participants are asked to walk as far as possible within a six-minute period, and the distance covered at the end is noted and recorded.

    Time frame: From Week 0, to Week 12, or to week 24, or to week 52

  3. Change in 20 Meter Walk Test

    the 20-meter walk test is a performance measurement of walking ability (measured as the total number of seconds it takes to walk 20 meters); lower scores indicate improved walking ability

    Time frame: From Week 0, to Week 12, or to week 24, or to week 52

  4. Change in Patient Global VAS

    Patients' global assessment score (Patient Global VAS) was assessed separately by the participant, who was unaware of the group assignment, with the use of a visual-analogue scale (VAS) (range, 0 to 10,with higher scores indicating greater pain).

    Time frame: From Week 0, to Week 12, or to week 24, or to week 52

  5. Change in Beck II Depression Inventory

    Beck II Depression Inventory (BDI), second edition, is a 21-question, validated, self-report instrument that measures the severity of depressive symptoms. Total scores range from 0-63, and higher scores reflect greater depressive symptoms. BDI scores ranging from 0-13 represent minimal depressive symptoms; scores from 14-19 are mild; scores from 20-28 are moderate; and scores from 29-63 represent severe depressive symptoms.

    Time frame: From Week 0, to Week 12, or to week 24, or to week 52

  6. Change in Arthritis Self-Efficacy Scale

    The Arthritis Self-Efficacy Scale is a self-report score measuring self-efficacy with respect to arthritis (range, 1 to 10, with higher scores indicating greater self-efficacy).

    Time frame: From Week 0, to Week 12, or to week 24, or to week 52

  7. Change in Short-Form Health Survey (SF-36) Mental Component Score (MCS)

    The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) Mental Component Score (MCS) is the summary score for the mental quality-of-life components (range, 0 to 100, with higher scores indicating better health status)

    Time frame: From Week 0, to Week 12, or to week 24, or to week 52

  8. Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC) Physical Function

    The WOMAC (version VA3.1) is a validated, self-administered, visual analogue scale specifically designed to evaluate knee and hip osteoarthritis. It has three subscales that are analyzed separately: pain (score range, 0-500), stiffness (0-200), and function (0-1700), with higher scores indicating more severe disease.

    Time frame: From Week 0, to Week 12, or to week 24, or to week 52

  9. Outcome Expectation Scale

    The Outcome Expectations for Exercise Scale (range, 1 to 5, with 1 indicating no expectations for exercise and 5 the highest expectations for exercise) is a self-report measure of outcome expectations for exercise.

    Time frame: Week 0

  10. Change in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Pain Subscale

    The WOMAC (version VA3.1) is a validated, self-administered, visual analogue scale specifically designed to evaluate knee and hip osteoarthritis. It has three subscales that are analyzed separately: pain (score range, 0-500), stiffness (0-200), and function (0-1700), with higher scores indicating more severe disease.

    Time frame: From Week 0, to week 24 or to week 52

07

Results

Posted Aug 4, 2016

Participant flow

Participant flow — Overall Study
MilestoneTai ChiPhysical Therapy
Started10698
Completed10698
Not completed00

Outcome measures

PrimaryChange in Western Ontario and McMaster Universities Arthritis Index (WOMAC)Pain Subscale From Baseline to 12 Weeks

The WOMAC (version: Visual Analog Scale 3.1) is a validated, self-administered, visual analogue scale specifically designed to evaluate knee and hip osteoarthritis. It has three subscales that are analyzed separately: pain (score range, 0-500), stiffness (0-200), and function (0-1700), with higher scores indicating more severe disease.

Time frame:
From Week 0 to Week 12
Reported as:
Mean · units on a scale
Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC)Pain Subscale From Baseline to 12 Weeks
units on a scaleTai ChiPhysical Therapy
Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC)Pain Subscale From Baseline to 12 Weeks-167.2 (-190.4 to -144.9)-143 (-167.4 to -118.6)
SecondaryChange in Medical Outcomes Short Form-36 PCS

The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) Physical Component Score (PCS) is the summary score for the physical quality-of-life components (range, 0 to 100, with higher scores indicating better health status)

Time frame:
From Week 0, to Week 12, or to week 24, or to week 52
Reported as:
Mean · units on a scale
Change in Medical Outcomes Short Form-36 PCS
units on a scaleTai ChiPhysical Therapy
week 126.3 (4.6 to 7.9)3.1 (1.4 to 4.8)
24 weeks7.1 (5.1 to 9.0)3.4 (1.4 to 5.5)
52 weeks6.3 (4.4 to 8.3)4.3 (2.3 to 6.4)
SecondaryChange in 6 Minute Walk

The 6 minute Walk Test is a measure of functional exercise capacity. Participants are asked to walk as far as possible within a six-minute period, and the distance covered at the end is noted and recorded.

Time frame:
From Week 0, to Week 12, or to week 24, or to week 52
Reported as:
Mean · meters
Change in 6 Minute Walk
metersTai ChiPhysical Therapy
Week 1228.6 (17.9 to 39.2)26.1 (14.9 to 37.4)
Week 2428.9 (16.6 to 41.2)24.5 (11.5 to 37.5)
Week 5227.1 (12.2 to 42.0)22.8 (7.0 to 38.6)
SecondaryChange in 20 Meter Walk Test

the 20-meter walk test is a performance measurement of walking ability (measured as the total number of seconds it takes to walk 20 meters); lower scores indicate improved walking ability

Time frame:
From Week 0, to Week 12, or to week 24, or to week 52
Reported as:
Mean · seconds
Change in 20 Meter Walk Test
secondsTai ChiPhysical Therapy
12 weeks-1.6 (-2.4 to -0.8)-1.1 (-2.0 to -0.2)
24 weeks-2.4 (-3.4 to -1.3)-1.2 (-2.2 to -0.1)
52 weeks-2.4 (-3.5 to -1.4)-1.0 (-2.1 to 0.2)
SecondaryChange in Patient Global VAS

Patients' global assessment score (Patient Global VAS) was assessed separately by the participant, who was unaware of the group assignment, with the use of a visual-analogue scale (VAS) (range, 0 to 10,with higher scores indicating greater pain).

Time frame:
From Week 0, to Week 12, or to week 24, or to week 52
Reported as:
Mean · units on a scale
Change in Patient Global VAS
units on a scaleTai ChiPhysical Therapy
12 weeks-0.3 (-0.3 to -0.2)-0.2 (-0.3 to -0.2)
24 weeks-2.4 (-2.93 to -1.88)-1.73 (-2.29 to -1.17)
52 weeks-1.84 (-2.48 to -1.21)-1.31 (-1.96 to -0.66)
SecondaryChange in Beck II Depression Inventory

Beck II Depression Inventory (BDI), second edition, is a 21-question, validated, self-report instrument that measures the severity of depressive symptoms. Total scores range from 0-63, and higher scores reflect greater depressive symptoms. BDI scores ranging from 0-13 represent minimal depressive symptoms; scores from 14-19 are mild; scores from 20-28 are moderate; and scores from 29-63 represent severe depressive symptoms.

Time frame:
From Week 0, to Week 12, or to week 24, or to week 52
Reported as:
Mean · units on a scale
Change in Beck II Depression Inventory
units on a scaleTai ChiPhysical Therapy
12 weeks-2.2 (-3.7 to -0.9)0.5 (-1 to 2)
24 weeks-1.7 (-3.1 to -0.4)0.2 (-1.3 to 1.7)
52 weeks-1.1 (-2.7 to 0.5)-0.003 (-1.6 to 1.6)
SecondaryChange in Arthritis Self-Efficacy Scale

The Arthritis Self-Efficacy Scale is a self-report score measuring self-efficacy with respect to arthritis (range, 1 to 10, with higher scores indicating greater self-efficacy).

Time frame:
From Week 0, to Week 12, or to week 24, or to week 52
Reported as:
Mean · units on a scale
Change in Arthritis Self-Efficacy Scale
units on a scaleTai ChiPhysical Therapy
12 weeks1.3 (0.8 to 1.8)0.8 (0.3 to 1.4)
24 weeks0.9 (0.4 to 1.4)0.9 (0.4 to 1.4)
52 weeks1.0 (0.5 to 1.5)0.7 (0.2 to 1.2)
SecondaryChange in Short-Form Health Survey (SF-36) Mental Component Score (MCS)

The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) Mental Component Score (MCS) is the summary score for the mental quality-of-life components (range, 0 to 100, with higher scores indicating better health status)

Time frame:
From Week 0, to Week 12, or to week 24, or to week 52
Reported as:
Mean · units on a scale
Change in Short-Form Health Survey (SF-36) Mental Component Score (MCS)
units on a scaleTai ChiPhysical Therapy
12 weeks1.6 (-0.1 to 3.2)-0.03 (-1.7 to 1.7)
24 weeks0.4 (-1.5 to 2.2)-0.7 (-2.7 to 1.4)
52 weeks-0.1 (-1.9 to 1.8)-1.5 (-3.4 to 0.4)
SecondaryChange in Western Ontario and McMaster Universities Arthritis Index (WOMAC) Physical Function

The WOMAC (version VA3.1) is a validated, self-administered, visual analogue scale specifically designed to evaluate knee and hip osteoarthritis. It has three subscales that are analyzed separately: pain (score range, 0-500), stiffness (0-200), and function (0-1700), with higher scores indicating more severe disease.

Time frame:
From Week 0, to Week 12, or to week 24, or to week 52
Reported as:
Mean · units on a scale
Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC) Physical Function
units on a scaleTai ChiPhysical Therapy
12 weeks-608.3 (-695.3 to -521.4)-114.1 (-240 to 118)
24 weeks-586.8 (-669.5 to -504.1)-455.7 (-543.1 to -368.4)
52 weeks-532.3 (-625.9 to -438.7)-444.0 (-541.3 to -346.7)
SecondaryOutcome Expectation Scale

The Outcome Expectations for Exercise Scale (range, 1 to 5, with 1 indicating no expectations for exercise and 5 the highest expectations for exercise) is a self-report measure of outcome expectations for exercise.

Time frame:
Week 0
Reported as:
Mean · units on a scale
Outcome Expectation Scale
units on a scaleTai ChiPhysical Therapy
Outcome Expectation Scale3.9 ± 0.53.9 ± 0.6
SecondaryChange in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Pain Subscale

The WOMAC (version VA3.1) is a validated, self-administered, visual analogue scale specifically designed to evaluate knee and hip osteoarthritis. It has three subscales that are analyzed separately: pain (score range, 0-500), stiffness (0-200), and function (0-1700), with higher scores indicating more severe disease.

Time frame:
From Week 0, to week 24 or to week 52
Reported as:
Mean · units on a scale
Change in Western Ontario and McMasters University Osteoarthritis Index (WOMAC) Pain Subscale
units on a scaleTai ChiPhysical Therapy
24 weeks-158.6 (-182.9 to -134.3)-124.3 (-150.0 to -98.5)
52 weeks-138.8 (-166.7 to -110.8)-121.0 (-150.0 to -91.9)

Adverse events

Collected over 12 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Tai Chi—0/106 (0%)0/106 (0%)
Physical Therapy—0/98 (0%)0/98 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Tai ChiPhysical TherapyTotal
Mean60.3 ± 10.560.1 ± 10.560.2 ± 10.5
Sex: Female, Male
Sex: Female, Male(Participants)Tai ChiPhysical TherapyTotal
Female7568143
Male313061
Race/Ethnicity, Customized
Race/Ethnicity, Customized(participants)Tai ChiPhysical TherapyTotal
White5454108
Black413172
Asian426
Other71118
Region of Enrollment
Region of Enrollment(participants)Tai ChiPhysical TherapyTotal
United States10698204
08

Study locations

1 site
  • Tufts Medical Center
    Boston, Massachusetts 02111, United States
09

References and documents

Publications

  • Wang C, Collet JP, Lau J. The effect of Tai Chi on health outcomes in patients with chronic conditions: a systematic review. Arch Intern Med. 2004 Mar 8;164(5):493-501. doi: 10.1001/archinte.164.5.493. PubMed 15006825 ↗
  • Wang C, Roubenoff R, Lau J, Kalish R, Schmid CH, Tighiouart H, Rones R, Hibberd PL. Effect of Tai Chi in adults with rheumatoid arthritis. Rheumatology (Oxford). 2005 May;44(5):685-7. doi: 10.1093/rheumatology/keh572. Epub 2005 Mar 1. No abstract available. PubMed 15741197 ↗
  • Wang C. Tai Chi improves pain and functional status in adults with rheumatoid arthritis: results of a pilot single-blinded randomized controlled trial. Med Sport Sci. 2008;52:218-229. doi: 10.1159/000134302. PubMed 18487901 ↗
  • Wang C, Schmid CH, Rones R, Kalish R, Yinh J, Goldenberg DL, Lee Y, McAlindon T. A randomized trial of tai chi for fibromyalgia. N Engl J Med. 2010 Aug 19;363(8):743-54. doi: 10.1056/NEJMoa0912611. PubMed 20818876 ↗
  • Wang C, Schmid CH, Hibberd PL, Kalish R, Roubenoff R, Rones R, McAlindon T. Tai Chi is effective in treating knee osteoarthritis: a randomized controlled trial. Arthritis Rheum. 2009 Nov 15;61(11):1545-53. doi: 10.1002/art.24832. PubMed 19877092 ↗
  • Wang C, Schmid CH, Hibberd PL, Kalish R, Roubenoff R, Rones R, Okparavero A, McAlindon T. Tai Chi for treating knee osteoarthritis: designing a long-term follow up randomized controlled trial. BMC Musculoskelet Disord. 2008 Jul 29;9:108. doi: 10.1186/1471-2474-9-108. PubMed 18664276 ↗
  • Reid KF, Price LL, Harvey WF, Driban JB, Hau C, Fielding RA, Wang C. Muscle Power Is an Independent Determinant of Pain and Quality of Life in Knee Osteoarthritis. Arthritis Rheumatol. 2015 Dec;67(12):3166-73. doi: 10.1002/art.39336. PubMed 26315282 ↗
  • Lee AC, Harvey WF, Price LL, Han X, Driban JB, Iversen MD, Desai SA, Knopp HE, Wang C. Dose-Response Effects of Tai Chi and Physical Therapy Exercise Interventions in Symptomatic Knee Osteoarthritis. PM R. 2018 Jul;10(7):712-723. doi: 10.1016/j.pmrj.2018.01.003. Epub 2018 Jan 31. PubMed 29407226 ↗
  • Lee AC, Harvey WF, Price LL, Han X, Driban JB, Wong JB, Chung M, McAlindon TE, Wang C. Mindfulness Is Associated With Treatment Response From Nonpharmacologic Exercise Interventions in Knee Osteoarthritis. Arch Phys Med Rehabil. 2017 Nov;98(11):2265-2273.e1. doi: 10.1016/j.apmr.2017.04.014. Epub 2017 May 12. PubMed 28506776 ↗
  • Lee AC, Driban JB, Price LL, Harvey WF, Rodday AM, Wang C. Responsiveness and Minimally Important Differences for 4 Patient-Reported Outcomes Measurement Information System Short Forms: Physical Function, Pain Interference, Depression, and Anxiety in Knee Osteoarthritis. J Pain. 2017 Sep;18(9):1096-1110. doi: 10.1016/j.jpain.2017.05.001. Epub 2017 May 10. PubMed 28501708 ↗
  • Wang C, Schmid CH, Iversen MD, Harvey WF, Fielding RA, Driban JB, Price LL, Wong JB, Reid KF, Rones R, McAlindon T. Comparative Effectiveness of Tai Chi Versus Physical Therapy for Knee Osteoarthritis: A Randomized Trial. Ann Intern Med. 2016 Jul 19;165(2):77-86. doi: 10.7326/M15-2143. Epub 2016 May 17. PubMed 27183035 ↗
  • Driban JB, Morgan N, Price LL, Cook KF, Wang C. Patient-Reported Outcomes Measurement Information System (PROMIS) instruments among individuals with symptomatic knee osteoarthritis: a cross-sectional study of floor/ceiling effects and construct validity. BMC Musculoskelet Disord. 2015 Sep 14;16:253. doi: 10.1186/s12891-015-0715-y. PubMed 26369412 ↗
  • Wang C, Iversen MD, McAlindon T, Harvey WF, Wong JB, Fielding RA, Driban JB, Price LL, Rones R, Gamache T, Schmid CH. Assessing the comparative effectiveness of Tai Chi versus physical therapy for knee osteoarthritis: design and rationale for a randomized trial. BMC Complement Altern Med. 2014 Sep 8;14:333. doi: 10.1186/1472-6882-14-333. PubMed 25199526 ↗

Individual participant data

Plan to share: Yes — De-identified participant data will be made available upon request.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 4, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01258985
Lead sponsor
Tufts Medical Center
Collaborators
National Center for Complementary and Integrative Health (NCCIH)
Responsible party
Sponsor
First posted
Dec 13, 2010
Start date
Mar 2011
Primary completion
Sep 2014
Completion
Sep 2014
Results posted
Aug 4, 2016
Last update
Aug 4, 2016

Study contacts

Chenchen Wang, MD, MSc
principal investigator · Tufts Medical Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion